Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
Zai Lab
ZLAB
$2.86B
| $264K | ﹤0.01% |
7,538
+2,836
| +60% | +$93.2K |
|
4027
Epsilon Energy
EPSN
$178M
| $262K | ﹤0.01% |
35,525
+35,303
| +15,902% | +$252K |
|
4028
Rocky Brands
RCKY
$351M
| $262K | ﹤0.01% |
11,813
+4,341
| +58% | +$82.7K |
|
4029
Ironwood Pharmaceuticals
IRWD
$727M
| $262K | ﹤0.01% |
365,450
+36,061
| +11% | +$28.3K |
|
4030
Definitive Healthcare
DH
$70.6M
| $261K | ﹤0.01% |
67,000
+4,822
| +8% | +$15.2K |
|
4031
Monopar Therapeutics
MNPR
$752M
| $261K | ﹤0.01% |
7,285
+7,273
| +60,608% | +$264K |
|
|
CRGX
4032
DELISTED
CARGO Therapeutics
CRGX
| $261K | ﹤0.01% |
63,260
+19,067
| +43% | +$81.7K |
|
4033
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.82B
| $260K | ﹤0.01% |
3,152
| – | – |
|
4034
Transportadora de Gas del Sur
TGS
$4.15B
| $259K | ﹤0.01% |
+10,000
| New | +$274K |
|
|
CHYM
4035
Chime Financial
CHYM
$11.8B
| $259K | ﹤0.01% |
+7,500
| New | +$247K |
|
4036
Franklin Financial Services
FRAF
$285M
| $258K | ﹤0.01% |
7,465
+7,445
| +37,225% | +$275K |
|
|
JCAP
4037
Jefferson Capital
JCAP
$1.31B
| $258K | ﹤0.01% |
+14,000
| New | +$261K |
|
4038
FinWise Bancorp
FINW
$190M
| $257K | ﹤0.01% |
17,118
+11,151
| +187% | +$164K |
|
4039
Vanguard Morningstar Mid-Cap ETF
VO
$110B
| $257K | ﹤0.01% |
3,668
| – | – |
|
4040
Pioneer Bancorp
PBFS
$418M
| $255K | ﹤0.01% |
21,220
+7,181
| +51% | +$82.5K |
|
|
EFXT
4041
Enerflex
EFXT
$2.57B
| $255K | ﹤0.01% |
32,339
+1,107
| +4% | +$7.92K |
|
4042
CS Disco
LAW
$270M
| $254K | ﹤0.01% |
58,224
+27,559
| +90% | +$108K |
|
4043
Acme United Corp
ACU
$224M
| $254K | ﹤0.01% |
6,134
+4,242
| +224% | +$167K |
|
4044
iShares Short Maturity Bond ETF
NEAR
$4.88B
| $254K | ﹤0.01% |
4,970
| – | – |
|
|
NXDT
4045
NexPoint Diversified Real Estate Trust
NXDT
$253M
| $254K | ﹤0.01% |
60,611
+24,206
| +66% | +$90.7K |
|
4046
KRONOS Worldwide
KRO
$912M
| $254K | ﹤0.01% |
40,945
+14,275
| +54% | +$97.9K |
|
|
SEG
4047
Seaport Entertainment Group
SEG
$379M
| $253K | ﹤0.01% |
13,543
+13,323
| +6,056% | +$256K |
|
4048
Bel Fuse Inc Class A
BELFA
$3.42B
| $252K | ﹤0.01% |
2,810
+1,049
| +60% | +$72.7K |
|
|
SCPH
4049
DELISTED
scPharmaceuticals
SCPH
| $252K | ﹤0.01% |
66,199
+19,586
| +42% | +$60.8K |
|
4050
EVI Industries
EVI
$194M
| $251K | ﹤0.01% |
11,514
+4,464
| +63% | +$79.6K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.